These results suggest that AR signalling is regulated by the canine REIC/Dkk-3 tumour suppressor, which interacts and interferes with SGTA functions and suppresses AR signalling in canine and human androgen-independent prostate cancer cell lines. Here, DKK3 is linked to prostate carcinoma.